Position history for AQR CAPITAL MANAGEMENT LLC's holdings in REGENERON PHARMACEUTICALS
AQR CAPITAL MANAGEMENT LLC holds 1.2M shares of REGN (REGENERON PHARMACEUTICALS), worth $946M as of 2026-Q1. The position was increased (+23.6% shares). REGN represents 0.4% of AQR CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$946M
Current Shares
1.2M
Total Value Change
+$747.4M
Total Shares Change
+1M
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.2M |
+23.6% |
| $946M |
| 0.4% |
| $766.66 |
46 |
| 2025-Q4 | Increased | 995,710 | +38.0% | $768.5M | 0.4% | $773.94 | 50 |
| 2025-Q3 | Increased | 721,354 | +528.7% | $405.6M | 0.3% | $560.05 | 60 |
| 2025-Q2 | Decreased | 114,742 | -51.4% | $59.7M | 0.0% | $519.56 | 0 |
| 2025-Q1 | Increased | 235,950 | +13.9% | $148.7M | 0.2% | $634.66 | 41 |
| 2024-Q4 | Decreased | 207,085 | -8.2% | $147.1M | 0.2% | $698.71 | 0 |
| 2024-Q3 | Increased | 225,534 | +19.1% | $235.2M | 0.3% | $1,036.94 | 43 |
| 2024-Q2 | Increased | 189,291 | +3.8% | $198.6M | 0.3% | $1,045.23 | 38 |